News Conference News Flu Vaccination Tied to Less MI in Hospitalized Patients Todd Neale March 13, 2019
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ACC 2019 Under 40, or 10 Years Older: MI Survivors Face Similar Long-term Mortality Risks Todd Neale March 07, 2019
News Conference News ISET 2019 Paclitaxel in PAD: What to Tell Patients While the Numbers Are Crunched Caitlin E. Cox January 28, 2019
News Conference News ISET 2019 PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research Caitlin E. Cox January 28, 2019
News Conference News WCC 2018 Is It Time to Loosen Restrictions on Saturated Fats and Salt? Todd Neale December 14, 2018
News Conference News WCC 2018 Rising CVD Threatens Middle East and North Africa Todd Neale December 13, 2018
News Conference News WCC 2018 Man’s Best Friend, Especially After an MI or Stroke Todd Neale December 11, 2018
News Conference News WCC 2018 E-Cigarettes: Plausible Heart Risks Flagged in New Review Todd Neale December 10, 2018
News Conference News WCC 2018 Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab Todd Neale December 07, 2018
News Conference News WCC 2018 True Resistant Hypertension Is Prevalent Worldwide Todd Neale December 07, 2018
News Conference News WCC 2018 CVD, Other Noncommunicable Diseases Hit Lower-Income Countries With Heavy Financial Burden Todd Neale December 06, 2018
News Conference News WCC 2018 WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai Todd Neale December 05, 2018
News Conference News AHA 2018 Greater Need for Cooperative Care in Women’s Heart Health, Two Studies Suggest Yael L. Maxwell November 16, 2018
News Conference News AHA 2018 EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits Michael O'Riordan November 16, 2018
News Conference News AHA 2018 Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study Michael O'Riordan November 15, 2018
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Conference News AHA 2018 AHA Puts Focus on the Impact of Violence on Cardiovascular Health Todd Neale November 14, 2018